Lucid Diagnostics Inc. (NASDAQ:LUCD) Q2 2025 Earnings Call Transcript

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q2 2025 Earnings Call Transcript August 13, 2025

Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is $-79.68549 EPS, expectations were $-0.09.

Operator: Good morning, and welcome to the Lucid Diagnostics Second Quarter 2025 Business Update Conference Call. [Operator Instructions] Please note that this event is being recorded. I would now like to turn the conference over to Matt Riley, Lucid Diagnostics Senior Director of Investor...